|
|
|
UNITED STATES
|
|
|
|
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
|
|
|
Washington, DC 20549
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Form 24F-2
|
|
|
|
|
Annual Notice of Securities Sold
|
|
|
|
|
Pursuant to Rule 24f-2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Read instructions at end of Form before preparing Form. Please print or type
|
|
|
|
|
|
|
|
|
|
1
|
Name and address of issuer:
|
|
|
|
|
|
|
DWS Securities Trust
|
|
|
|
|
|
345 Park Avenue
|
|
|
|
|
|
New York NY 10154-0004
|
|
|
|
|
|
|
|
|
|
2
|
The name of each series or class of securities for which this Form is filed.
|
o
|
|
|
|
(If the Form is being filed for all series and classes of securities of the issuer,
|
|
|
|
|
check the box but do not list series or classes)
|
|
|
|
|
|
|
|
|
|
|
|
DWS Health Care Fund
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3
|
Investment Company Act File Number:
|
811-02021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Act File Number:
|
|
002-36238
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4(a).
|
Last day of fiscal year for which this Form is filed:
|
May 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4(b).
|
Check box if this Form is being filed late (i.e., more than 90 calendar days
|
o
|
|
|
|
after the end of the issuer’s fiscal year). (See Instruction A.2)
|
|
|
|
Note: If the Form is being filed late, interest must be paid on the registration fee due.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
|
|
4(c).
|
Check box if this is the last time the issuer will be filing this Form.
|
|
|
|
|
|
|
|
|
|
5
|
Calculation of registration fee:
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Aggregate sale price of securities sold during the fiscal year pursuant to section 24(f):
|
$64,050,197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii)
|
Aggregate price of securities redeemed or repurchased during the fiscal year:
|
$48,195,197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii)
|
Aggregate price of securities redeemed or repurchased during any prior fiscal
|
$89,632,497
|
|
|
|
year ending no earlier than October 11, 1995 that were not previously used
|
|
|
|
|
to reduce registration fees payable to the Commission:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(iv)
|
Total available redemption credits [add items 5(ii) and 5(iii)]:
|
|
$137,827,694
|
|
|
|
|
|
|
|
(v)
|
Net sales - if item 5(i) is greater than item 5(iv)
|
|
$0.00
|
|
|
[subtract item 5(iv) from item 5(i)]:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(vi)
|
Redemption credits available for use in future years
|
|
|
|
|
- if item 5(i) is less than item 5(iv) [subtract item 5(iv) from item 5(i)]:
|
($73,777,497)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(vii)
|
Multiplier for determining registration fee (See Instruction C.9):
|
|
0.0001364
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(viii)
|
Registration fee due [multiply item 5(v) by item 5(vii)]
|
|
|
|
|
(enter “0” if no fee is due):
|
|
|
$0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6
|
Prepaid Shares
|
|
|
|
|
|
|
|
|
|
|
|
If the response to item 5(i) was determined by deducting an amount of securities that
|
|
|
|
were registered under the Securities Act of 1933 pursuant to Rule 24e-2 as in effect before
|
|
|
|
October 11, 1997, then report the amount of securities (number of shares or other units) deducted here:
|
0
|
|
|
|
|
|
|
|
|
If there is a number of shares or other units that were registered pursuant to Rule 24e-2
|
|
|
|
remaining unsold at the end of the fiscal year for which this form is filed that are available
|
|
|
|
for use by the issuer in future fiscal years, then state that number here:
|
|
0
|
|
|
|
|
|
|
|
7
|
Interest due - if this Form is being filed more than 90 days after the end of the issuer’s
|
$0.00
|
|
|
fiscal year (see Instruction D):
|
|
|
|
|
|
|
|
|
|
|
8
|
Total amount of the registration fee due plus any interest due [line 5(viii) plus line 7]:
|
|
$0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9
|
Date the registration fee and any interest payment was sent to the Commission’s lockbox depository:
|
|
|
|
|
|
|
|
|
|
Method of Delivery:
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SIGNATURES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This report has been signed below by the following persons on behalf of the issuer
|
|
|
|
|
and in the capacities and on the dates indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By (Signature and Title)*
|
/s/Caroline Pearson
|
Date
8/2/13
|
|
|
|
|
|
|
|
|
|
Caroline Pearson, Chief Legal Officer
|
|
|
|
|
|
|
|
|
|
|
*Please print the name and title of the signing officer below the signature.
|
|
|
